What is the primary purpose of maintaining asepsis and line patency for IV infusions during aeromedical transport?

What is the primary purpose of maintaining asepsis and line patency for IV infusions during aeromedical transport?

• A. To prevent catheter-related infection and ensure reliable delivery
• B. To speed up care by skipping sterile technique
• C. To save on sterile supplies
• D. To allow rapid bolus administration regardless of indications

Answer: (A)

Maintaining a sterile, patent IV line during aeromedical transport protects the patient from infection and guarantees that medications and fluids are delivered reliably, even in the moving, resource-limited aircraft environment. Asepsis reduces the risk of catheter-related infections and bloodstream infections by preventing introduction of bacteria during access, connection, and line care when access is less than ideal and care opportunities are limited. A patent line ensures that the infusion continues without interruption; in flight, lines are subject to movement, turbulence, and potential dislodgement or occlusion, which can otherwise stop therapy and delay critical treatment. By keeping the system clean and free of occlusions, you avoid interruptions in medication dosing, preserve accurate administration rates, and minimize the need for additional access attempts in a setting where repeated access is challenging. In short, these practices are about patient safety and treatment continuity in the unique and demanding context of aeromedical care.